Next Century Growth Investors’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Next Century Growth Investors’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-109,738	Closed	-$2.08M	–	164
2016 Q4	$2.08M	Buy	109,738 +78,309	+249%	+$1.5M	0.13%	129
2016 Q3	$697K	Buy	+31,429	New	+$590K	0.03%	163
2015 Q3	–	Sell	-150,818	Closed	-$3.9M	–	203
2015 Q2	$3.9M	Buy	150,818 +641	+0.4%	+$16.2K	0.13%	165
2015 Q1	$3.29M	Buy	+150,177	New	+$3.24M	0.12%	172

Other funds holding ENTL

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

DGI

Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Next Century Growth Investors's ENTL Position: Q1 2017 in Review

Next Century Growth Investors sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2017, closing a stake of 109,738 shares — an estimated $2.08M sold.

Next Century Growth Investors first reported a position in ENTL in Q1 2015 and held it in 4 quarters. The position peaked at $3.9M in Q2 2015. 69 funds tracked by Wall St. Rank hold ENTL as of Q1 2017.

Next Century Growth Investors reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
Next Century Growth Investors sold 109,738 Entellus Medical, Inc. Common Stock shares in Q1 2017, an estimated $2.08M.
Next Century Growth Investors first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 4 quarters.
Next Century Growth Investors's Entellus Medical, Inc. Common Stock position peaked at $3.9M in Q2 2015.
69 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2017.

Based on Next Century Growth Investors's 13F filing for Q1 2017, filed 12 May 2017.